News

BEMA Buprenorphine is a transmucosal form of buprenorphine, a partial mu-opiate receptor agonist, which incorporates a bioerodible mucoadhesive (BEMA) technology. BEMA Buprenorphine is currently in phase III trials

The new test will be designed to enable early treatment before reactivation of the TB disease, as a follow up to those who test positive for latent TB.

According to Korea Food and Drug Administration (KFDA), Supect, a drug manufactured by Ilyang Pharmaceutical has been approved to treat leukemia in those resistant to currently available anti-leukemia

The new system is said to facilitate the handling of liquid-based cytology and other types of liquid samples that are processed by clinical laboratories across the globe. According

Strides Arcolab is also securing investment bank Jefferies’ advice on divestment of softgel and anti-retro viral (ARV) drug manufacturing, timesofindia.indiatimes.com reported. Strides Arcolab plans to lay more emphasis

The manufacturing units including Southwest Synthetic Pharma Company, Intec Product, Suzhoudawn Ray’s Pharma and Hisoanchuannan Pharma Company will be inspected by the Indian officials. The cancellation of many

VGX-100 is a human antibody that acts against the human VEGF-C protein and is indicated in the treatment for cancers, particularly glioblastoma and metastatic colorectal cancers. The company

BCX4208 is an oral, once-daily novel enzyme inhibitor, and is been studied as an add-on therapy to xanthine oxidase inhibitors to address unmet medical needs in patients with

Inhibitex, a biopharmaceutical company, is primarily focuses on the development of nucleotide/nucleoside analogs for the treatment of hepatitis C virus (HCV). The company’s lead HCV asset is INX-189,